Association between polymorphisms of LEP, LEPR, DRD2, HTR2A and HTR2C genes and risperidone- or clozapine-induced hyperglycemia

OBJECTIVE: To determine whether genetic polymorphisms related to pharmacodynamics with metabolic adverse effects, namely leptin promoter (LEP) rs7799039, leptin receptor rs1137101, dopamine D2 rs4436578, serotonin 5-HT2A rs6313, and serotonin 5-HT2C rs518147 and rs12836771, are associated with hyper...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmgenomics Pers Med
Main Authors: Puangpetch, Apichaya, Srisawasdi, Pornpen, Unaharassamee, Weerapon, Jiratjintana, Napa, Vanavanan, Somlak, Punprasit, Suweejuk, Na Nakorn, Chalitpon, Sukasem, Chonlaphat, Kroll, Martin H
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6689662/
https://ncbi.nlm.nih.gov/pubmed/31496784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S210770
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados